John Nuss - 05 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Scientific Officer
Signature
/s/ Christopher Krueger, As Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
05 Dec 2022
Net transactions value
-$1,411,311
Form type
4
Filing time
06 Dec 2022, 16:00:12 UTC
Previous filing
04 Feb 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $1,315,316 -46,706 -15% $28.16 261,990 05 Dec 2022 Direct F1
transaction VTYX Common Stock Sale $95,996 -3,294 -1.3% $29.14 258,696 05 Dec 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 46,706 shares sold in the price range of $28.00 to $28.99. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 3,294 shares sold in the price range of $29.00 to $29.89. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.